The workforce wellness index: A method for valuing US workers' health

Journal of Occupational and Environmental Medicine

Volumn 55, Issue 3, 2013, Pages 272-279

  Goetzel, Ron ^a,b   Pickens, Gary ^a   Kowlessar, Niranjana ^a,b  

^a IBM WATSON HEALTH   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; EMPLOYEE; EXERCISE; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; OBESITY; OCCUPATIONAL HEALTH; OCCUPATIONAL HEALTH SERVICE; OCCUPATIONAL SAFETY; PHYSICAL EXAMINATION; PREVALENCE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCORING SYSTEM; STRESS; WELLBEING; WORKFORCE WELLNESS INDEX SCORE;

ADOLESCENT; ADULT; COST OF ILLNESS; DATABASES, FACTUAL; FEMALE; HEALTH BEHAVIOR; HEALTH BENEFIT PLANS, EMPLOYEE; HEALTH EXPENDITURES; HEALTH STATUS INDICATORS; HUMANS; INSURANCE CLAIM REPORTING; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, ECONOMIC; MULTIVARIATE ANALYSIS; OCCUPATIONAL HEALTH; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84875221235     PISSN: 10762752     EISSN: 15365948     Source Type: Journal    
DOI: 10.1097/JOM.0b013e318278274e     Document Type: Article

References (38)

1. H.R. 3590 - 111th Congress: Patient Protection and Affordable Care Act. In GovTrack.us (database of federal legislation). 2009. http://www.govtrack.us/ congress/bill.xpd?billh111-3590&tab=reports. Accessed June 1, 2011
2. Centers for Medicare and Medicaid Services; Office of the Actuary; and National Health Statistics Group. National Health Care Expenditures Data
3. Thorpe KE, Howard DH. The rise in spending among Medicare beneficiaries: The role of chronic disease prevalence and changes in treatment intensity. Health Aff (Millwood). 2006;25:w378-w388
4. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med ;46: 398-412
5. Stewart WF, Ricci JA, Chee E, Morganstein D. Lost productive work time costs from health conditions in the United States: Results from the American Productivity Audit. J Occup Environ Med. 2003;45: 1234-1246
6. Goetzel RZ. Do prevention or treatment services save money? The wrong debate. Health Aff (Millwood). 2009;28: 37-41
7. Aldana SG. Financial impact of health promotion programs: A comprehensive review of the literature. Am J Health Promot. 2001;15: 296-320
8. Cavallo D. Using return on investment analysis to evaluate health promotion programs: Challenges and opportunities. Health Promot Econ Issue Briefs ;1(3):1-4
9. Covel S. Companies win as workers lose pounds. Wall Street Journal. 2008 Available at: Http://online.wsj.com/article/SBI121563900447940537.html. Accessed February 1, 2012
10. Goetzel RZ, Ozminkowski RJ. The health and cost benefits of work site health-promotion programs. Annu Rev Public Health. 2008;29: 303-323
11. Anderson LM, Quinn TA, Glanz K, et al. The effectiveness of worksite nutrition and physical activity interventions for controlling employee overweight and obesity; a systematic review. Am J Prev Med. 2009;37: 340-357
12. Baicker K, Cutler D, Song Z. Workplace wellness programs can generate savings. Health Aff (Millwood). 2010;29: 304-311
13. Soler RE, Leeks KD, Razi S, et al. A systematic review of selected interventions for worksite health promotion. The assessment of health risks with feedback. Am J Prev Med. 2010;38:S237-S262
14. Anderson D, Whitmer R, Goetzel R, Ozminkowski R, Wasserman J, Serxner S. The relationship between modifiable health risks and group-level health care expenditures. Am J Health Promot. 2000;15: 45-52
15. Burton W, Chen C, Conti D, Schultz A, Edington D. Measuring the relationship between employees' health risk factors and corporate pharmaceutical expenditures. J Occup Environ Med. 2003;45: 793-802
16. Goetzel R, Anderson D, Whitmer R, Ozminkowski R, Dunn R,Wasserman J. The relationship between modifiable health risks and health care expenditures: An analysis of themulti-employerHEROhealth risk and cost database. JOccup Environ Med. 1998;40: 843-854
17. Yen L, Schultz A, Schnueringer E, Edington D. Financial costs due to excess health risks among active employees of a utility company. J Occup Environ Med. 2006;48: 896-905
18. Maciosek MV, Coffield AB, Edwards NM, Flottemesch TJ, Goodman MJ, Solberg LI. Priorities among effective clinical preventive services: Results of a systematic review and analysis. Am J Prev Med. 2006;31: 52-61
19. Russell LB. Preventing chronic disease: An important investment, but don't count on cost savings. Health Aff (Millwood). 2009;28: 42-45
20. Centers for Disease Control and Prevention. Framing an economic evaluation Available at: Http://www.cdc.gov/owcd/EET/Framing3/1.html. Accessed January 20, 2012
21. Cohen JT, Neumann PJ. The cost savings and cost-effectiveness of clinical preventive care. RobertWood Johnson Research Synthesis Report;18. September 2009
22. Schwappach DL, Boluarte TA, SuhrckeM. The economics of primary prevention of cardiovascular disease; a systematic review of economic evaluations. Cost Eff Resour Alloc. 2007;5: 5
23. Committee on Comparative Effectiveness Research Prioritization. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. Atlanta, GA: The National Academies Press; 2009
24. Drummond M, Sculpher M. Common methodological flaws in economic evaluations. Med Care. 2005;43: 5-14
25. Goetzel RZ, Liss-Levinson RC, Goodman N, Kennedy JX. Development of a community-wide cardiovascular risk reduction assessment tool for small rural employers in upstate New York. Prev Chronic Dis. 2009;6:A65
26. Hussey PS, Eibner C, Ridgely MS, McGlynn EA. Controlling U.S. health care spending - separating promising from unpromising approaches. N Engl J Med. 2009;361: 2109-2111
27. Centers for Disease Control and Prevention.Public Health Surveillance Slide Set. 2009. Available at: Http://www.cdc.gov/ncphi/disss/nndss/phs/ overview. htm. Accessed January 20, 2012
28. van Staa TP, Leufkens HG, Zhang B, Smeeth L. A comparison of cost effectiveness using data from randomized trials or actual clinical practice: Selective cox-2 inhibitors as an example. PLoS Med. 2009;6(12):e1000194
29. Leutzinger J, Ozminkowski R, Dunn R, et al. Projecting health care costs using the HERO database and prevalence rates of lifestyle risks at Union Pacific Railroad. Am J Health Promot. 2000;15: 35-44
30. Ozminkowski RJ, Goetzel RZ, Chang S, Long S. The application of two health and productivity instruments at a large employer. J Occup Environ Med. 2004;46: 635-648
31. Goetzel RZ, Baker KM, Short ME, et al. First-year results of an obesity prevention program at the Dow Chemical Company. J Occup Environ Med ;51: 125-138
32. Goetzel RZ, Roemer EC, Pei X, et al. Second-year results of an obesity prevention program at the Dow Chemical Company. J Occup Environ Med ;52: 291-302
33. Baker KM, Goetzel RZ, Pei X, et al. Using a return-on-investment estimation model to evaluate outcomes from an obesity management worksite health promotion program. J Occup Environ Med. 2008;50: 981-990
34. Goetzel RZ, Carls GS, Wang S, et al. The relationship between modifiable health risk factors and medical expenditures, absenteeism, short-term disability, and presenteeism among employees at Novartis. J Occup Environ Med ;51: 487-499
35. Henke RM, Carls GS, Short ME, et al. The relationship between health risks and health and productivity costs among employees at Pepsi Bottling Group. J Occup Environ Med. 2010;52: 519-527
36. Carls GS, Goetzel RZ, Henke RM, Bruno J, Isaac F, McHugh J. The impact of weight gain or loss on health care costs for employees at the Johnson & Johnson Family of Companies. J Occup Environ Med. 2011;53: 8- 16
37. Goetzel RZ, Ozminkowski RJ, Bruno JA, Rutter KR, Isaac F, Wang S. The long-term impact of Johnson & Johnson's Health & Wellness Program on employee health risks. J Occup Environ Med. 2002;44: 417-424
38. Kowlessar NM, Goetzel RZ, Carls GS, Tabrizi MJ, Guindon A. The relationship between 11 health risks and medical and productivity costs for a large employer. J Occup Environ Med. 2011;53: 468-477